For research access and to learn how you can work with Alembic Global Advisors please email Stephen Matthews, stephen.matthews@alembicglobal.com.
Research Archive
Institutional Coverage
December 15, 2025
NOC: Raising Rating to Overweight and Increasing Target Price to USD662
Key Points We’re raising our rating on shares of NOC to Overweight and increasing our target price by USD26 to USD662. This is the first time we’ve updated our forecast post...
December 12, 2025
Chemical Stocks 2026 Preview: Value’s Sharpest Rebound Candidate
Key Points Beatable setup: Destocking is largely done, U.S. cost advantage intact, and 2026 consensus embeds no recovery—leaving clear upside to estimates Tightening tailwinds: Anti-dumping actions and accelerating global capacity cuts are...
December 11, 2025
AVAV: Modest Target Price Reduction Post F2Q, but Reiterate Overweight Rating as Growth Catalysts Remain
Key Points We’re updating our forecast for AVAV post the firm's F2Q earnings release Tuesday night, and we're reiterating our Overweight rating on the shares despite the sharp sell-off yesterday. We’ve...
December 9, 2025
Tronox – Rare Earths Option Gains Credibility With EFA/EXIM Support; Raising TP to USD6
Key Points EFA and EXIM signaled up to USD600m in coordinated, non-binding support, validating Tronox’s role in a Western-aligned REE supply chain Financing hinges on a customer-anchored project structure; cracking & leaching...